Adherium (ASX.ADR) is a global leader in digital health technologies that address sub-optimal medication use in chronic disease. Its Hailie™ platform has been independently proven to improve medication adherence and health outcomes for patients with chronic respiratory disease. Adherium has the broadest range of "smart"​ devices for respiratory medications globally. Adherium's Hailie™ sensors attach to prescription inhalers to provide reminders and monitoring of inhaler usage. The Hailie™ platform uses wireless communications technology to provide real time data collection and reporting from the Company's inhalers.